Whether you're launching a new drug or have a new set of indications for an existing product, you need provider input regarding appropriate use and unforeseen challenges to adoption. Through our new Emerging Perspectives program, we'll assemble a panel of physicians to provide case-based feedback on your product using primary market research.

Before meeting, we'll conduct surveys to see how providers would typically respond to the scenarios you propose. Then we'll facilitate an in-person question and answer session to help the panel better understand your drug. Afterward, we'll conduct quantitative and qualitative assessments to see if product education affected providers' approaches. The results will help you identify barriers to adoption and refine your go-to-market strategy.